Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - MYRIAD GENETICS INC | mygn-ex312_9.htm |
| EX-31.1 - EX-31.1 - MYRIAD GENETICS INC | mygn-ex311_6.htm |
| 10-Q - 10-Q - QUARTER ENDED 12/31/17 - MYRIAD GENETICS INC | mygn-10q_20171231.htm |
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended December 31, 2017 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: February 7, 2018 |
|
Date: February 7, 2018 |
||
|
By: |
/s/ Mark C. Capone |
|
By: |
/s/ R. Bryan Riggsbee |
|
Mark C. Capone |
|
R. Bryan Riggsbee |
||
|
President and Chief Executive Officer |
|
Executive Vice President, Chief Financial Officer |
||